Abstract

Assessing drug disposition in the skin after the application of a topical formulation is difficult. It is hypothesized that reverse iontophoresis (RI), which can extract charged/polar molecules for monitoring purposes, may provide a noninvasive approach for the assessment of local drug bioavailability. The passive and RI extraction of salicylic acid (SA) and nicotine (NIC) from porcine skin in vitro was assessed after a simple solution of the former and a transdermal patch of the latter had been applied for 24 and 8 h, respectively. Immediately after this “passive skin loading”, the amount of drug in the stratum corneum (SC) and “viable” tissue (VT) was measured either (a) after tape-stripping and subsequent solvent extraction of both skin layers or (b) following RI extraction over 4 h. Parallel experiments were then performed in vivo in healthy volunteers; in this case, the VT was not sampled and the skin loading period for NIC was only 4 h. RI extraction of both drugs was significantly higher (in vitro and in vivo) than that achieved passively, and the cumulative RI extraction profiles as a function of time were mathematically analyzed using a straightforward compartmental model. Best-fit estimates of drug amounts in the SC and VT (A SC,0 and A VT,0, respectively) at the end of “loading” and two first-order rate constants describing transfer between the model compartments were then determined. The in vitro predictions of A SC,0 and A VT,0 were in excellent agreement with the experimental results, as was the value of the former in vivo. The rate constants derived from the in vitro and in vivo results were also similar. In summary, the results provide proof-of-concept that the RI method has the potential to noninvasively assess relevant metrics of drug bioavailability in the skin.

Original languageEnglish
Pages (from-to)234-244
Number of pages11
JournalMolecular Pharmaceutics
Volume21
Issue number1
Early online date7 Dec 2023
DOIs
Publication statusPublished - 1 Jan 2024

Bibliographical note

Funding: This research was funded by L’Oréal.

Funding

This research was funded by L’Oréal. The authors thank Dr. Shaun Reeksting for analytical expertise and Giacomo Ageno and Ben McGovern for mathematical input. M.B.D.C. and R.H.G. were funded in part by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) (award 1-U01-FD006533). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.

FundersFunder number
U.S. Department of Health and Human Services1-U01-FD006533
U.S Food and Drug Administration

    Keywords

    • dermatopharmacokinetics
    • noninvasive drug monitoring
    • reverse iontophoresis
    • skin
    • topical bioavailability

    ASJC Scopus subject areas

    • Drug Discovery
    • Molecular Medicine
    • Pharmaceutical Science

    Fingerprint

    Dive into the research topics of 'Reverse iontophoresis: non-invasive assessment of topical drug bioavailability'. Together they form a unique fingerprint.

    Cite this